Vivalto Santé

What Vivalto Santé does

Vivalto Santé is a French privately held healthcare group operating as a GIE (Groupement d'Intérêt Économique) under French law, structured as an 'Entreprise à mission' and built on a medical-capital partnership governance model. Founded in 2009 and headquartered in Saint Grégoire near Paris, the group operates 52 hospitals and clinics in France delivering the full continuum of inpatient and ambulatory care — prevention, screening, diagnostics, treatments, examinations, and specialty hospitalizations — to approximately 6 million patients annually. The network is supported by 8,300 practitioners and 28,000 employees across 10,700+ beds and places, with a territorial organization designed to provide local access to comprehensive care.

The group's product surface extends beyond core hospital services to include a patient portal (patient.vivalto-sante.com) for digital engagement, a dedicated clinical research platform (recherche.vivalto-sante.com) using SIGAPS-SIGREC systems to track practitioner research output and secure MERRI public funding, the Institut Vivalto Santé research and innovation institute, and a robotic orthopedic surgery program built around the Velys robot. Internationally, Vivalto Santé acquired Centene Corporation's Spanish and Central European businesses in 2022, adding Ribera Salud, Torrejón Salud, and Pro Diagnostics Group in Spain, Slovakia, and the Czech Republic.

Revenue is generated primarily through the delivery of healthcare services to individual patients across its owned and operated facility network, supplemented by public MERRI research allocations for qualifying clinical research activity. The group goes to market via its owned hospital and clinic footprint (52 facilities in France plus international operations), supported by direct-to-patient digital channels (website, patient portal, online bill payment) and practitioner recruitment portals. Pricing for healthcare services is not publicly disclosed, consistent with reimbursement driven by French public payer tariff structures and complementary insurance rather than published list prices. No revenue figure, funding history, or institutional investor composition is disclosed in available sources.

Name

Vivalto Santé

Legal name

GIE Vivalto Santé

Website

https://vivalto-sante.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Vivalto Santé is a French privately held hospital operator running 52 hospitals and clinics in France plus international facilities in Spain, Slovakia, and the Czech Republic, serving 6 million patients annually through 8,300 practitioners and 28,000 employees under a practitioner-capital partnership governance model.

Ownership category

akta.pro rank

Product category

Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), Hospitals (622)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

International/Medical Tourism Hospital Systems (HLAFAAAN)

Keywords

• Hospital healthcare services
• Ambulatory hospitalization
• Preventive screening care
• Robotic orthopedic surgery
• Clinical research platform

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Healthcare services delivery: Vivalto Santé generates revenue through operating its network of hospitals and clinics providing medical services including prevention, screening, care pathways, hospitalizations (ambulatory and full), treatments, examinations, and specialized medical services to patients in France and Europe.
2. Clinical research funding (MERRI): The group receives MERRI (Missions d'Enseignement, de Recherche, de Reference et d'Innovation) allocations for clinical research activities conducted by its practitioners and establishments, contributing to research output visibility and funding.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Vivalto Santé operates a network of 52 hospitals and clinics in France (with international sites in Spain, Slovakia, and the Czech Republic) delivering comprehensive healthcare services including prevention, screening, care pathways, ambulatory and full hospitalizations, home care support, specialized treatments, examinations, and robotic-assisted orthopedic surgery using the Véllys robot. Revenue is generated through service fees for direct patient care delivery, supplemented by MERRI public funding for clinical research.

Product overview

Vivalto Santé operates as a major European hospital operator with a platform-plus-services architecture. The core offering is a network of 52 hospitals and clinics in France, supplemented by the patient portal for digital patient engagement, a clinical research platform supporting practitioner scientific projects via SIGAPS-SIGREC systems, the Institut Vivalto Santé for research and innovation, and Robot Vélys for robotic orthopedic surgery. Recent acquisitions include healthcare providers Torrejón Salud, Ribera Salud, and Pro Diagnostics Group across Spain, Slovakia, and the Czech Republic.

Differentiator

Problem solved

Functional benefit

Products and services

• Vivalto Santé Hospital and Clinic Network Network of 52 hospitals and clinics in France providing comprehensive medical services including prevention, screening, care pathways, ambulatory and full hospitalizations, examinations, and specialized treatments for the general patient population.
• Patient Portal (Espace Patient) Online portal at patient.vivalto-sante.com where patients of Vivalto Santé's hospitals and clinics can access medical services, schedule appointments, view records, and pay bills online.
• Clinical Research Platform (Espace Recherche clinique) Online platform at recherche.vivalto-sante.com supporting practitioners within the group in managing scientific projects, clinical research activity, and MERRI (Teaching, Research, Reference and Innovation Missions) funding allocations through the SIGAPS-SIGREC research tracking systems.
• Institut Vivalto Santé Research and innovation institute within the Vivalto Santé group supporting clinical research activity, medical innovation, and MERRI-funded research output for the group's 8,300 practitioners across Europe.
• Robot Véllys - Robotic Orthopedic Surgery Robotic-assisted surgical service using the Véllys robot in knee surgery, providing precise, personalized orthopedic care to patients at Vivalto Santé hospitals.
• Hospitalization Services (Ambulatory, Complete, and Home Care) Multi-modal hospitalization services covering ambulatory day-surgery (ambulatoire), full inpatient stays (hospitalisation complète), and home care accompaniment (accompagnement à domicile) for patients across the Vivalto Santé network.

Quantifiable outcome

• 6 million patients welcomed in Europe annually
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered major.

• Centene CorporationmajorStrategic or Co-development Partner · 25 July 2022Centene Corporation sold its Spanish and Central European healthcare businesses to Vivalto Santé as part of its strategic portfolio review. The transaction includes various healthcare providers and clinics in Spain, Slovakia, and the Czech Republic, subject to regulatory approvals and expected to close by end of 2022.
• Torrejón SaludmajorStrategic or Co-development Partner · 25 July 2022Acquired by Vivalto Santé from Centene Corporation as part of the portfolio streamlining. Healthcare provider in the acquired Spanish and Central European business portfolio.
• Ribera SaludmajorStrategic or Co-development Partner · 25 July 2022Acquired by Vivalto Santé from Centene Corporation as part of the portfolio streamlining. Healthcare provider in the acquired Spanish and Central European business portfolio.
• Pro Diagnostics GroupmajorStrategic or Co-development Partner · 25 July 2022Acquired by Vivalto Santé from Centene Corporation as part of the portfolio streamlining. Diagnostic services provider in the acquired Spanish and Central European business portfolio.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Ramsay Santé: Ramsay Santé is the leading French private hospital operator and Vivalto's most direct domestic competitor, operating a comparable network of hospitals and clinics across France with similar medical-surgical services and practitioner engagement model.
• Elsan: Elsan is one of the two largest private hospital groups in France alongside Ramsay and Vivalto, operating a network of clinics and hospitals with overlapping medical specialties, ambulatory and inpatient services, and practitioner partnership structures.
• Capio (part of Ramsay Santé): Capio is a European hospital operator (now part of Ramsay Santé) with pan-European presence including France, the Nordics, and Germany, making it directly comparable to Vivalto's cross-border hospital strategy.
• Quirónsalud: Quirónsalud is the largest private hospital operator in Spain (part of Fresenius Helios), directly comparable to Vivalto's newly acquired Spanish assets (Torrejón Salud, Ribera Salud) and a competitive benchmark for Spanish private hospital operations.

Broad incumbents

• Fresenius Helios: Fresenius Helios is the largest hospital operator in Europe, headquartered in Germany with operations in Germany, Spain, and Latin America. It is a broader incumbent serving as a benchmark for European private hospital consolidation and clinical scale.
• Asklepios Kliniken: Asklepios is one of Germany's leading private hospital groups with significant European presence, operating acute care hospitals comparable to Vivalto's general medical and surgical facilities across multiple German federal states.
• Mediclinic International: Mediclinic operates private hospitals across Southern Africa, the UAE, and Switzerland (including Hirslanden), providing a global benchmark for multi-country private hospital operations, practitioner engagement, and clinical quality models similar to Vivalto's.

Regional players

• Spire Healthcare: Spire Healthcare is the second-largest private hospital group in the UK, operating a comparable network of acute care hospitals serving private and NHS-funded patients, providing a benchmark for European private hospital operations and capital intensity.

Others

• Centene Corporation: Centene is a US managed care company that divested its Spanish and Central European hospital businesses (acquired by Vivalto in 2022). It is a peer in the sense of being a counterparty and benchmark for European healthcare divestiture strategy.

Emerging players

• Korian: Korian is a major European healthcare services group focused on long-term care, clinics, and home care with significant French presence, offering a partial overlap with Vivalto's ambulatory and home-based care offerings within its territorial model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/vivaltosante
• Facebookfacebook.com/vivaltosante
• LinkedInlinkedin.com/company/vivaltosante

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivalto Santé